Results 31 to 40 of about 9,936 (203)

Molecular elucidations of hutchinson-gilford progeria syndrome: A hope for managing horrors of premature aging in children

open access: yesPakistan Journal of Pharmaceutical Sciences, 2020
Hutchinson-Gilford progeria syndrome (or Progeria) is an exceptionally rare genetic disorder in children. It is caused by a rare point mutation in the lamin gene. It encodes lamin A protein, resulting in the de-shaping of nuclear membrane.
Bilal Ahmed   +5 more
doaj   +1 more source

The decision‐making process and criteria in selecting candidate drugs for progeria clinical trials

open access: yesEMBO Molecular Medicine, 2016
Hutchinson–Gilford progeria syndrome (progeria) is an extremely rare premature aging disease with a population prevalence of 1 in 20 million. Nevertheless, propelled by the discovery of a causal mutation in the lamin A/C gene (LMNA) (De Sandre‐Giovannoli
Leslie B Gordon   +3 more
doaj   +1 more source

Early Onset Diabetes in Two Children due to Progeria, a Monogenic Disease of DNA Repair

open access: yesJCRPE, 2020
Progeria syndrome is a rare disorder in childhood which causes accelerated systemic aging. Due to the accelerated aging process, disorders which normally occur only in old age will appear in these children at a much younger age.
Martin Holder, Valerie Schwitzgebel
doaj   +1 more source

SAMMY-seq reveals early alteration of heterochromatin and deregulation of bivalent genes in Hutchinson-Gilford Progeria Syndrome

open access: yesNature Communications, 2020
Hutchinson-Gilford progeria syndrome is a genetic disease where an aberrant form of Lamin A disrupts chromatin by interfering with lamina associated domains.
Endre Sebestyén   +11 more
doaj   +1 more source

Conservatively managed extradural haematoma in a child with progeria

open access: yesInterdisciplinary Neurosurgery, 2019
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterised by premature ageing. We report a case of a 13-year-old girl with HGPS who presented with an extradural haematoma following head injury.
Kapil Mohan Rajwani   +4 more
doaj   +1 more source

The Potentials of Methylene Blue as an Anti-Aging Drug

open access: yesCells, 2021
Methylene blue (MB), as the first fully man-made medicine, has a wide range of clinical applications. Apart from its well-known applications in surgical staining, malaria, and methemoglobinemia, the anti-oxidative properties of MB recently brought new ...
Huijing Xue   +2 more
doaj   +1 more source

Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome [PDF]

open access: yes, 2018
Aging, the main risk factor for cardiovascular disease (CVD), is becoming progressively more prevalent in our societies. A better understanding of how aging promotes CVD is therefore urgently needed to develop new strategies to reduce disease burden ...
del Campo, Lara   +5 more
core   +1 more source

Lessons in aging from Myc knockout mouse models

open access: yesFrontiers in Cell and Developmental Biology, 2023
Despite MYC being among the most intensively studied oncogenes, its role in normal development has not been determined as Myc−/− mice do not survival beyond mid-gestation.
Edward V. Prochownik   +4 more
doaj   +1 more source

Implant Supported Prosthesis in a Patient with Progeria: Case Report

open access: yesBiomolecules & Biomedicine, 2009
Prosthodontic rehabilitation can be accomplished with fixed, overdenture, complete, or implant-retained prostheses. Dental treatment overcomes the patient’s functional, psychological, esthetic and phonation problems.
Gözlem Ceylan   +3 more
doaj   +1 more source

Progeria (Hutchinson-Gilford Syndrome): Literature Review and Clinical Case

open access: yesВопросы современной педиатрии, 2022
Progeria, or Hutchinson-Gilford Syndrome is a rare disease from the group of laminopathies characterized by premature aging with skin, bones and cardiovascular system lesions.
Natalia V. Buchinskaya   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy